2014
DOI: 10.5045/br.2014.49.4.280
|View full text |Cite
|
Sign up to set email alerts
|

Extramedullary plasmacytoma of the thyroid: report of a rare case

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 6 publications
0
16
0
1
Order By: Relevance
“…While the prognosis of EMP is excellent, multiple myeloma carries a grim prognosis. However, even if the prognosis of EMP is relatively favorable, a local recurrence or a progression to multiple myeloma has been described in up to 20% of the cases [5,8].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…While the prognosis of EMP is excellent, multiple myeloma carries a grim prognosis. However, even if the prognosis of EMP is relatively favorable, a local recurrence or a progression to multiple myeloma has been described in up to 20% of the cases [5,8].…”
Section: Discussionmentioning
confidence: 99%
“…Extramedullary plasmacytoma (EMP) has been defined as an autonomous proliferation of monoclonal plasma cells with varying degrees of differentiation, producing a circumscribed mass or diffuse infiltration [1][2][3]. The most common sites of EMP are the head, neck, lymph nodes and skin, but it can also be found at various other sites such as bone, nasal cavities, oral cavity, breast, soft tissue, testis and thyroid [1,2,[4][5][6][7][8]. This is a rare plasma cell neoplasm, constituting approximately 3-6% of all plasma cell neoplasms [1,3,4,5,[7][8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…First, profuse uterine bleeding is an extremely rare mode of initial presentation of MM [11]. Female reproductive organs, breasts, skeletal muscle, and thyroid gland, are exceedingly rare sites of EMD reported mostly in isolated case reports [1113]. To the best of our knowledge, this is the only case report of MM with simultaneous involvement of the female reproductive system, thyroid and breasts.…”
Section: Discussionmentioning
confidence: 99%
“…According to 2017 WHO classification for plasma cell neoplasms (PCN), it includes non-IgM monoclonal gammopathy of undetermined significance (MGUS), plasma cell myeloma (PCM), plasmacytoma, monoclonal immunoglobulin deposition disease and PCN with associated paraneoplastic syndrome. Plasmacytoma is further subdivided into solitary plasmacytoma of bone (SPB) and extramedullary system (10), central nervous system (11), thyroid (12), lymph nodes (13), breast (14), testes (15), retroperitoneum (16), or skin (17) etc. Before being diagnosed, it is necessary to perform relevant examinations to ascertain whether there is Bence-Jonce protein in the blood and urine, osteolytic lesions in spine and pelvis, renal insufficiency and hypercalcemia, to completely rule out multiple myeloma (1,18).…”
Section: Introductionmentioning
confidence: 99%